|Bid||6.00 x 3100|
|Ask||0.00 x 1800|
|Day's Range||6.26 - 6.56|
|52 Week Range||4.56 - 12.02|
|Beta (5Y Monthly)||0.99|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 06, 2020 - Aug. 10, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Oct. 07, 2008|
|1y Target Est||9.06|
Gloucestershire Hospitals NHS Foundation Trust, located in the United Kingdom, has successfully gone live with the latest addition to its Allscripts electronic health record, despite the ongoing novel coronavirus outbreak.
2bPrecise™ Precision Health™ platform named recipient of Microsoft’s 2020 Health Innovation Awards in the "Reimagine Healthcare" category.
Allscripts Healthcare Solutions (NASDAQ: MDRX) today announces that Canada’s Sunnybrook Health Sciences Centre has extended its relationship with Allscripts for an additional seven years to provide software and support for Allscripts Patient Flow. This extension includes the purchase by Sunnybrook of Allscripts Managed Services to manage the Patient Flow solution 24 hours, seven days a week and 365 days a year. The Allscripts Managed Services team will optimize the solution, implement customizations and new functionality and assist with change control and expansion activities.
Allscripts (NASDAQ: MDRX) has been recognized as the top-rated electronic health record vendor for ambulatory practices and inpatient hospitals according to new survey results from Black Book Research. The annual client satisfaction survey features responses collected from more than 2,000 individual users of electronic health record platforms in the U.S. and are collected from all areas of the organization including IT, administrative staff and end-user clinicians.
Allscripts (NASDAQ: MDRX) business unit Veradigm™, a leading provider of data and technology solutions, today announced the signing of an agreement with Surescripts to enhance its Veradigm AccelRx™ specialty medication fulfillment solution with Surescripts Specialty Patient Enrollment. The agreement will enable AccelRx to support healthcare providers in more quickly fulfilling prescriptions for hundreds more types of specialty medications by incorporating Surescripts’ expansive health information network, further streamlining healthcare providers’ management of specialty medication within their electronic health record workflow.
AllScripts (MDRX) delivered earnings and revenue surprises of -35.71% and -1.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2020.
Allscripts (NASDAQ: MDRX) has been recognized as the top-rated inpatient EHR vendor for hospitals 101-250 beds, according to new survey results from Black Book Research.
We think intelligent long term investing is the way to go. But that doesn't mean long term investors can avoid big...
Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) today announced that, due to the public health impact of the novel coronavirus (COVID-19) pandemic, related governmental actions and the importance of safeguarding the health of its stockholders, employees and representatives, Allscripts will hold its 2020 Annual Meeting of Stockholders (the "Annual Meeting") solely by means of remote communication (i.e., a virtual-only meeting). Stockholders will not be able to attend the Annual Meeting in person.
AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
As a leading provider of data and technology solutions, Allscripts (NASDAQ: MDRX) business unit, Veradigm, is at the forefront of the fight to help providers and researchers, and the patients they serve. The company is committed to leveraging its technology to help providers identify patients at risk for the virus and ensure they have the information and tools needed to help them. In addition, Veradigm is a founding member of a consortium dedicated to providing the data necessary for advancing COVID research.
Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended March 31, 2020 after the close of stock market hours on Thursday, May 7, 2020. Allscripts management plans to host a conference call and webcast to discuss the company's earnings and other information at 4:30 p.m. Eastern Time that same day.
Zoom Video, Capri, Teladoc Health, Allscripts Healthcare Solutions and Masimo highlighted as Zacks Bull and Bear of the Day
AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Allscripts (MDRX) offers simplified telehealth implementation to health systems through FollowMyHealth to provide telehealth visit capabilities to their patients quickly.
Allscripts (NASDAQ: MDRX) clients across the nation have signed up to deliver telehealth visit capabilities in a quick timeframe to their patients. The company has created a specialized plan for clients to swiftly implement telehealth at their organizations through its EHR-agnostic patient engagement platform, FollowMyHealth.
CarePort Health, a wholly-owned subsidiary of Allscripts (NASDAQ: MDRX) that connects 1,000 hospitals with 180,000 post-acute providers, is launching the COVID-19 Transitions of Care ("TOC") Hub as an educational resource to share current learnings, latest trends and best practices for safe and effective transitions for COVID-19 patients across the healthcare system. Hospitals across the US send 18 million referrals annually through CarePort to skilled nursing, home health, hospice, long-term acute and acute rehabilitation, which accounts for nearly 40% of all acute to post-acute transitions nationally. Given that CarePort customers are on the front lines of the pandemic, the TOC Hub aims to disseminate critical lessons learned in real time.
Allscripts (NASDAQ: MDRX) is taking several steps to further its commitment to help fight the global spread of COVID-19. The company is working closely with health agencies and governments around the world to keep abreast of changes and partnering with clients to share and enable their Allscripts solutions to help combat the spread of the virus and manage their patients.